9 results about "Myalgia" patented technology

The invention belongs to the technical field of massage control, and discloses a fascia pain point massage robot adjusting and controlling method and system. The method comprises the steps of obtaining initial information of a user, and generating a massage path; acquiring parameter information of key point positions on the massage path, and generating massage pressure of each key point position; feedback information and parameter information of each key point in the massage process are obtained, and the reasonability of massage pressure of the key points is judged; dynamically adjusting the massage pressure based on the judgment result; when the massage path is determined, the appropriate meridian channel can be selected as the massage path according to the association degree condition of each meridian channel and all the pain points, the traditional Chinese medicine meridians and the muscle pain points are integrated to determine the massage path, the treatment accuracy can be improved, and symptom recovery is facilitated.

The utility model relates to the technical field of medical equipment, and discloses a postoperative upper limb edema recovery device based on mammary gland and thyroid gland, which comprises an L-shaped frame, and the edge of the L-shaped frame close to the upper surface is fixedly connected with a storage frame. When the postoperative upper limb edema recovery device for the mammary gland and the thyroid gland is used, an upper limb is placed in the massage sleeve, the control panel is electrically connected with the air pump, so that medical staff can conveniently open the air pump through the control panel, and air is continuously input into the air bag cushion from the inflation hose through the air inlet hole by the input end of the air pump; the air bag cushion continuously expands to drive the silica gel cushion to be continuously close to the edema part of the upper limb, too stuffy skin caused by too close is conveniently prevented through the air holes, the air pump is controlled to continuously inflate and deflate the air bag cushion so that the air bag cushion can be fully attached to the upper limb of a patient, the comfortable attaching feeling is achieved, meanwhile, muscular pain and stiffness are relieved, and muscle relaxation is promoted; and pain and discomfort are reduced.

The application belongs to the technical field of medicine, and particularly relates to the use of icariin in the preparation of lipid-lowering drugs with muscle protection. In view of the adverse reactions such as myalgia and myositis caused by the existing statins in the lipid-lowering process, the muscle protection effect of icariin in the lipid-lowering process is evaluated by constructing a high-fat cell model and a high-fat Caenorhabditis elegans model. It is found through research that icariin can significantly reduce the content of triglyceride, total cholesterol and lipid droplet accumulation in high-fat cells, reduce the content of triglyceride and lipid droplet accumulation in high-fat C. elegans, and prolong the lifespan of high-fat C. elegans. Further research shows that icariin can improve the muscle state of high-fat C. elegans while lowering lipid, and the specific performance is the enhancement of the movement ability of C. elegans and the maintenance of the structural integrity of body wall muscle fibers. The application discloses the unique advantage of icariin in the lipid-lowering process, that is, the muscle protection effect, and can solve the adverse reactions such as myalgia and myositis caused by the existing statins, and has an important clinical application prospect.

This disclosure relates to compounds of formula (I-1) or (I-2): This relates to TIFF2026513962000575.tif74102. The compounds of this disclosure can inhibit the activity of tyrosine kinase 2 (TYK2), for example, in inflammation, autoimmune diseases, neuroinflammation, arthritis, rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, lupus nephritis, arthritis, osteoarthritis, gouty arthritis, pain, fever, pulmonary sarcoidosis, silicosis, cardiovascular disease, atherosclerosis, myocardial infarction, thrombosis, congestive heart failure and cardiac reperfusion injury, cardiomyopathy, stroke, ischemia, reperfusion injury, cerebral edema, head trauma, neurodegeneration, liver disease, inflammatory bowel disease, Crohn's disease, ulcerative colitis, nephritis, retina It is useful in treating diseases or disorders such as inflammation, retinopathy, macular degeneration, glaucoma, diabetes (type 1 and type 2), diabetic neuropathy, viral and bacterial infections, myalgia, endotoxin shock, toxic shock syndrome, autoimmune diseases, osteoporosis, multiple sclerosis, endometriosis, menstrual pain, vaginitis, candidiasis, cancer, fibrosis, obesity, muscular dystrophy, polymyositis, dermatomyositis, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, vitiligo, alopecia, Alzheimer's disease, skin flushing, eczema, psoriasis, atopic dermatitis, and sunburn. This disclosure further provides a method for preparing the compound.

To provide a compound of formula (I) as described herein, pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods for using these compounds, salts, and compositions to treat viral infections. [Solution] The present invention relates to a novel 1,3-dioxoindene compound that is an inhibitor of picornaviruses, including coxsackievirus, enterovirus, echovirus, poliovirus, and rhinovirus, and is therefore useful for treating viral infections, including polio, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular diseases, hepatitis A, myositis, myocarditis, pancreatitis, diabetes mellitus, epidemic myalgia, encephalitis, common cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis, or otitis media.

Apparatus and methods are described including obtaining from a subject at least a first and second blood product sample. A first infrared spectrum of the first blood product sample is obtained by performing a first infrared spectroscopy measurement, and a second infrared spectrum of the second blood product sample is obtained by performing a second infrared spectroscopy measurement. A computer processor analyzes the first and second infrared spectra, and at least partially in response thereto, determines a status of the subject with respect to fibromyalgia syndrome, rheumatoid arthritis, psoriatic arthritis, and / or ankylosing spondylitis. Other applications are also described.

This invention discloses a topical anti-inflammatory traditional Chinese medicine composition and its application, as well as an anti-inflammatory gel patch and its preparation method, belonging to the field of traditional Chinese medicine technology. The topical anti-inflammatory traditional Chinese medicine composition, by weight, comprises the following components: 30-120 parts of *Sinomenium acutum* and 0.35-1.4 parts of *Ilex cornuta* oil. The combination of the active components *Sinomenium acutum* and *Ilex cornuta* oil achieves a synergistic effect, ensuring the efficacy of the active ingredients. Pharmacological studies have shown that the topical anti-inflammatory traditional Chinese medicine composition of this invention exhibits significant therapeutic effects in alleviating biomarkers related to osteoarthritis, frozen shoulder, soft tissue injury, and muscle pain, which is of great significance for improving patients' quality of life.

The application discloses a traditional Chinese medicine preparation for treating systemic lupus erythematosus. It solves the problem of poor effect of the current treatment of systemic lupus erythematosus. The formula is as follows: 10-30 parts of raw Rehmannia glutinosa, 6-12 parts of cortex Paeoniae, 6-12 parts of Ophiopogon japonicus, 6-12 parts of red peony root, 20-40 parts of Scutellaria baicalensis, 20-40 parts of mulberry bark, 20-40 parts of Artemisia annua, 6-12 parts of Cyathula officinalis, and 6-12 parts of raw licorice. The traditional Chinese medicine preparation for treating systemic lupus erythematosus has a novel composition and pure traditional Chinese medicine ingredients, has the functions of nourishing yin and clearing heat and promoting blood circulation to remove blood stasis, has a good treatment effect on various types of systemic lupus erythematosus, and has a very good curative effect on symptoms of low fever, five heat, night sweat, hair loss, fresh red rash, dry mouth and throat pain, oral ulcer, joint and muscle pain, heel pain, and soreness of waist and knees, and has no toxic side effects.

Described herein is system, kit, or method for determining genus and species of one or more fastidious microorganisms. Also described herein is system, kit, or method for detecting and identifying one or more fastidious microorganisms in a subject experiencing fatigue, myalgia, or a neurological symptom.